- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
- 187 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2025
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 186 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 117 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- July 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2025
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- September 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- September 2024
- 115 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2024
- 115 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
- 140 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- April 2024
- 114 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- December 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- December 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- December 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- December 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP

Biomanufacturing is a sub-sector of biotechnology that focuses on the production of biopharmaceuticals, medical devices, and other products derived from living organisms. It involves the use of biotechnology processes such as genetic engineering, cell culture, and fermentation to produce these products. The biomanufacturing market is driven by the increasing demand for biopharmaceuticals, medical devices, and other products derived from living organisms. This demand is driven by the growing prevalence of chronic diseases, the increasing aging population, and the need for more effective treatments.
The biomanufacturing market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies in the market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more